Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Selumetinib Sulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 164,338Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Koselugo

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Koselugo

    Selumetinib

    arrow
    Peptide Therapy Summit
    Not Confirmed

    Brand Name : Koselugo

    United Kingdom
    arrow
    Peptide Therapy Summit
    Not Confirmed

    AstraZeneca

    Selumetinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 38

    2019 Revenue in Millions : 0

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Koselugo

    Selumetinib

    arrow
    Peptide Therapy Summit
    Not Confirmed

    Brand Name : Koselugo

    United Kingdom
    arrow
    Peptide Therapy Summit
    Not Confirmed

    AstraZeneca

    Selumetinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 108

    2020 Revenue in Millions : 38

    Growth (%) : 184

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Koselugo

    Selumetinib

    arrow
    Peptide Therapy Summit
    Not Confirmed

    Brand Name : Koselugo

    United Kingdom
    arrow
    Peptide Therapy Summit
    Not Confirmed

    AstraZeneca

    Selumetinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 208

    2021 Revenue in Millions : 108

    Growth (%) : 93

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Koselugo

    Selumetinib

    arrow
    Peptide Therapy Summit
    Not Confirmed

    Brand Name : Koselugo

    United Kingdom
    arrow
    Peptide Therapy Summit
    Not Confirmed

    AstraZeneca

    Selumetinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 331

    2022 Revenue in Millions : 208

    Growth (%) : 59

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF